In the current issue of Diabetes Care, Davis et al. report on a small study exploring the safety of substituting exenatide for insulin therapy in an attempt to take patients off insulin.
Read More »Diabetes In Control
Weight Control Slows Progression of Atherosclerosis in Type 1’s
Increasing calcium formation in the coronary arteries (CAC) is the best predictor of a coronary artery disease (CAD) event in patients with type 1 diabetes, researchers report
Read More »Sleep Duration Linked to Diabetes Risk
Too little sleep or too much may increase the risk of type 2 diabetes, according to the results of a new study.
Read More »New Indication for Rosuvastatin
The US FDA has granted an additional indication for rosuvastatin (Crestor, AstraZeneca), as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol.
Read More »Walking 2 ½ Hours A Week Prevents Diabetes
Men who stay highly active with age may have a lower risk of developing diabetes than those who taper off their exercise levels, a study suggests.
Read More »Rimonabant Improves Glucose Control
Based on the results of the SERENADE study, showing an improvement in blood glucose control with rimonabant 20mg, the European Commission will endorse the opinion of the European Commission to include it into the label..
Read More »Screening for Pre-Diabetes Cost-Effective
Screening overweight and obese adults for pre-diabetes is cost-effective, according to a study by researchers at RTI International, the Centers for Disease Control and Prevention.
Read More »More Evidence of Cardiovascular Safety of Second-Generation Sulfonylureas
Diabetes patients who used second-generation sulfonylureas had no excess one-year mortality after a myocardial infarction, researchers said….
Read More »Age at Diagnosis of Type 1 Diabetes Linked to Long-Term Outcomes
Patients diagnosed between 0 and 9 years of age were significantly less likely to have had a heart attack then those diagnosed between 10 and 13 years of age.
Read More »DHEA Reduces AGE Formation in Type 2 Diabetes
In a new report, DHEA significantly reduced oxidative stress parameters in both plasma and peripheral blood mononuclear cells, and its administration was followed by a 50% decrease in levels of pentosidine (a marker of AGE formation).
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.